BioCentury
ARTICLE | Company News

Boehringer Ingelheim infectious news

September 24, 2012 7:00 AM UTC

Boehringer said it will discontinue its virology research program following a review of its research areas and priorities. The company said, "the demands for medical innovation are shifting significan...